z
Sharma, N.L., M.D., D.C.H. (Lond.), F.R.S.T.M.& H. (Eng.), D.T.M., D.P.H. (Cal.), Professor and Head of the Department of Pediatrics Lahori, U.C., M.D., D.C.H., Research Scholar and Mehta, S.K., B.Sc., M.B.,B.S., D.C.H., Research Scholar, King George’s Medical College, Lucknow, U.P., India.
Liver diseases continue to be one of the major causes of morbidity and mortality in children. The treatment of most of the diseases remains non-specific, expensive and unrewarding. With this background the effectiveness of Liv.52 was evaluated in 155 cases of different hepatic disorders in childhood.
MATERIAL AND METHODS
The present study was ca
Studies on Liv.52 in hepatic disorders
Sharma, N.L., M.D., D.C.H. (Lond.), F.R.S.T.M.& H. (Eng.), D.T.M., D.P.H. (Cal.), Professor and Head of the Department of Pediatrics Lahori, U.C., M.D., D.C.H., Research Scholar and Mehta, S.K., B.Sc., M.B.,B.S., D.C.H., Research Scholar, King George’s Medical College, Lucknow, U.P., India.
Liver diseases continue to be one of the major causes of morbidity and mortality in children. The treatment of most of the diseases remains non-specific, expensive and unrewarding. With this background the effectiveness of Liv.52 was evaluated in 155 cases of different hepatic disorders in childhood.
MATERIAL AND METHODS
The present study was ca